Ident. | Authors (with country if any) | Title |
---|
000005 |
Franziska Maier [Allemagne] ; Catharine J. Lewis [Allemagne] ; Nina Horstkoetter [Allemagne] ; Carsten Eggers [Allemagne] ; Elke Kalbe [Allemagne] ; Mohammad Maarouf [Allemagne] ; Jens Kuhn [Allemagne] ; Mateusz Zurowski [Canada] ; Elena Moro [France] ; Christiane Woopen [Allemagne] ; Lars Timmermann [Allemagne] | Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach |
000013 |
Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada] | Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic |
000019 |
M A Harris [Canada] ; Marion [Canada] ; Tsui [Canada] ; Shen [Canada] ; Teschke [Canada] | 281 Occupations and Parkinson’s disease in a population-based case-control study |
000036 |
Malgosia M. Pakulska [Canada] ; Brian G. Ballios [Canada] ; Molly S. Shoichet [Canada] | Injectable hydrogels for central nervous system therapy |
000039 |
Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis] | Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study |
000048 |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
000090 |
Yan Rolland [France] ; Marc Vérin [France] ; Christine A. Payan [France] ; Simon Duchesne [Canada] ; Eduard Kraft [Allemagne] ; Till K. Hauser [Allemagne] ; Josef Jarosz [Royaume-Uni] ; Neil Deasy [Royaume-Uni] ; Luc Defevbre [France] ; Christine Delmaire [France] ; Didier Dormont [France] ; Albert C. Ludolph [Allemagne] ; Gilbert Bensimon [France] ; P Nigel Leigh [Royaume-Uni, France] | A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability |
000100 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia |
000123 |
Francisco A. Ponce [États-Unis] ; Andres M. Lozano [Canada] | The most cited works in Parkinson's disease |
000131 |
Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | The curious case of phenocopies in families with genetic Parkinson's disease |
000133 |
Brian Jeynes [Canada] ; John Provias [Canada] | The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease |
000136 |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
000137 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
000139 |
Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis] | Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia |
000165 |
Jonathan Kimmelman [Canada] ; Katherine Duckworth [Canada] ; Tim Ramsay [Canada] ; Tiffini Voss [États-Unis] ; Bernard Ravina [États-Unis] ; Marina Elena Emborg [États-Unis] | Risk of surgical delivery to deep nuclei: A meta‐analysis |
000183 |
Masayuki Watanabe [Japon, Canada] ; Douglas P. Munoz [Canada] | Probing basal ganglia functions by saccade eye movements |
000184 |
Wassilios G. Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher G. Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José A. Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David M. Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
000186 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
000196 |
Roberto Cilia [Canada, Italie] ; Sang Soo Cho [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; Ji Hyun Ko [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada] | Pathological gambling in patients with Parkinson's disease is associated with fronto‐striatal disconnection: A path modeling analysis |
000208 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
000221 |
Ronald B. Postuma [Canada] ; Jean-François Gagnon [Canada] ; Mélanie Vendette [Canada] ; Catherine Desjardins [Canada] ; Jacques Y. Montplaisir [Canada] | Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder |
000234 |
Dario C. Angeles [Singapour] ; Bong-Hwa Gan [Singapour] ; Luisa Onstead [États-Unis] ; Yi Zhao [Singapour] ; Kah-Leong Lim [Singapour] ; Justus Dachsel [États-Unis] ; Heather Melrose [États-Unis] ; Matt Farrer [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Dennis W. Dickson [États-Unis] ; Eng-King Tan [Singapour] | Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress‐induced neuronal death |
000247 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in neuroimaging |
000254 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
000287 |
Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] | Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
000292 |
Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis] | Impulse control disorders in parkinson disease: A multicenter case–control study |
000306 |
Marianna Orlova [Canada] ; Tania Di Pietrantonio [Canada] ; Erwin Schurr | Genetics of infectious diseases: hidden etiologies and common pathways |
000307 |
Owen A. Ross [États-Unis] ; Karen N. Conneely [États-Unis] ; Tao Wang [États-Unis] ; Carles Vilarino-Guell [États-Unis, Canada] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Alex Rajput [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Elan D. Louis [États-Unis] ; Lorraine N. Clark [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] ; Claudia M. Testa [États-Unis] | Genetic variants of α‐synuclein are not associated with essential tremor |
000338 |
Alberto J. Espay [États-Unis] ; Joe P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Emily Dunn [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Dustin A. Heldman [États-Unis] | Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease |
000346 |
J. C. Dachsel [États-Unis] ; C. Wider [États-Unis, Suisse] ; C. Vilari O-Güell [États-Unis] ; J. O. Aasly [Norvège] ; A. Rajput [Canada] ; A. H. Rajput [Canada] ; T. Lynch [Irlande (pays)] ; D. Craig [Royaume-Uni] ; A. Krygowska-Wajs [Pologne] ; B. Jasinska-Myga [États-Unis] ; G. Opala ; M. Barcikowska [Pologne] ; K. Czyzewski [Pologne] ; R. Wu [Taïwan] ; M. G. Heckman [États-Unis] ; R. J. Uitti [États-Unis] ; Z. K. Wszolek [États-Unis] ; M. J. Farrer [États-Unis] ; O. A. Ross [États-Unis] | Death‐associated protein kinase 1 variation and Parkinson’s disease |
000376 |
Ronald B. Postuma [Canada] ; Jacques Montplaisir [Canada] ; Paola Lanfranchi [Canada] ; Hélène Blais [Canada] ; Sylvie Rompré [Canada] ; Roberto Colombo [Italie] ; Jean-François Gagnon [Canada] | Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder |
000379 |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study |
000381 |
Mélanie Vendette [Canada] ; Jean-François Gagnon [Canada] ; Jean-Paul Soucy [Canada] ; Nadia Gosselin [Canada] ; Ronald B. Postuma [Canada] ; Maria Tuineag [Canada] ; Isabelle Godin [Canada] ; Jacques Montplaisir [Canada] | Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder |
000389 |
Viduth K. Chaugule [Royaume-Uni] ; Lynn Burchell [Royaume-Uni] ; Kathryn R. Barber [Canada] ; Ateesh Sidhu [Royaume-Uni] ; Simon J. Leslie [Royaume-Uni] ; Gary S. Shaw [Canada] ; Helen Walden [Royaume-Uni] | Autoregulation of Parkin activity through its ubiquitin‐like domain |
000401 |
Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease |
000404 |
Valerie Cullen [États-Unis] ; S. Pablo Sardi [États-Unis] ; Juliana Ng [Canada] ; You-Hai Xu [États-Unis] ; Ying Sun [États-Unis] ; Julianna J. Tomlinson [Canada] ; Piotr Kolodziej [Canada] ; Ilana Kahn [États-Unis] ; Paul Saftig [Allemagne] ; John Woulfe [Canada] ; Jean-Christophe Rochet [États-Unis] ; Marcie A. Glicksman [États-Unis] ; Seng H. Cheng [États-Unis] ; Gregory A. Grabowski [États-Unis] ; Lamya S. Shihabuddin [États-Unis] ; Michael G. Schlossmacher [États-Unis, Canada] | Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing |
000407 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
000416 |
Anthony E. Lang [Canada] | A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials |
000421 |
Lorena Etcheverry [Uruguay] ; Shahan Khatchadourian [Canada, États-Unis] ; Mariano Consens [Canada, États-Unis] | Quality Assessment of MAGE-ML Genomic Datasets Using DescribeX |
000443 |
S W Hung [Canada, États-Unis] ; G M Adeli [Canada] ; T. Arenovich [Canada] ; S H Fox [Canada] ; A E Lang [Canada] | Patient perception of dyskinesia in Parkinson's disease |
000464 |
Q J Almeida [Canada] ; C A Lebold [Canada] | Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment? |
000478 |
R B Postuma [Canada] ; J F Gagnon [Canada] ; J. Montplaisir [Canada] | Clinical prediction of Parkinson's disease: planning for the age of neuroprotection |
000509 |
En Huang [Canada] ; Dianbo Qu [Canada] ; Yi Zhang [Canada] ; Katerina Venderova [Canada] ; M. Emdadul Haque [Canada] ; Maxime W. C. Rousseaux [Canada] ; Ruth S. Slack [Canada] ; John M. Woulfe [Canada] ; David S. Park [Canada] | The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death |
000515 |
Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada] | The nonmotor symptoms of Parkinson's disease—An overview |
000522 |
Dylan G. Harwood [États-Unis] ; Ari Kalechstein [États-Unis] ; Warren W. Barker [États-Unis] ; Silvia Strauman [États-Unis] ; Peter St. George-Hyslop [Canada] ; Casandra Iglesias [États-Unis] ; David Loewenstein [États-Unis] ; Ranjan Duara [États-Unis] | The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease |
000526 |
Jean-François Gagnon [Canada] ; Ronald B. Postuma [Canada] ; Steve Joncas [Canada] ; Catherine Desjardins [Canada] ; Véronique Latreille [Canada] | The Montreal Cognitive Assessment: A screening tool for mild cognitive impairment in REM sleep behavior disorder |
000530 |
Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
000534 |
Adrian P. Fawcett [Canada] ; Esther G. González [Canada] ; Elena Moro ; Martin J. Steinbach [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Subthalamic Nucleus Deep Brain Stimulation Improves Saccades in Parkinson's Disease |
000536 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD) |
000559 |
R. Nandhagopal ; Andre R. Troiano ; Edwin Mak ; Michael Schulzer ; Mary Catherine Bushnell [Canada] ; Alexander Jon Stoessl | Response to Heat Pain Stimulation in Idiopathic Parkinson's Disease |
000563 |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease |
000615 |
Laura Silveira-Moriyama [Royaume-Uni] ; Renato Pupi Munhoz [Brésil] ; Margarete De J. Carvalho [Brésil] ; Salmo Raskin [Brésil] ; Ekaterina Rogaeva [Canada] ; Patricia De C. Aguiar [Brésil] ; Rodrigo A. Bressan [Brésil] ; Andre C. Felicio [Brésil] ; Orlando G. P. Barsottini [Brésil] ; Luiz Augusto F. Andrade [Brésil] ; Hsin F. Chien [Brésil] ; Vincenzo Bonifati [Pays-Bas] ; Egberto R. Barbosa [Brésil] ; Helio A. Teive [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | Olfactory heterogeneity in LRRK2 related Parkinsonism |
000649 |
Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède] | Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia |
000655 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
000660 |
Cory Toth [Canada] ; Kim Breithaupt [Canada] ; Shaohua Ge [Canada] ; Yanjun Duan [Canada] ; Joan M. Terris [Canada] ; Anita Thiessen [Canada] ; Samuel Wiebe [Canada] ; Douglas W. Zochodne [Canada] ; Oksana Suchowersky [Canada] | Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease |
000665 |
Zhen Ni [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Involvement of the cerebellothalamocortical pathway in Parkinson disease |
000668 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
000678 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders |
000684 |
Rodger J. Elble [États-Unis] ; Oksana Suchowersky [Canada] ; Stephanie Shaftman [Canada, États-Unis] ; William J. Weiner [États-Unis] ; Peng Huang [États-Unis] ; Barbara Tilley [États-Unis] | Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease |
000689 |
Moonhee Lee [Canada] ; Anna Sparatore [Italie] ; Piero Del Soldato [Italie] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Hydrogen sulfide‐releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation |
000723 |
Ruksana Azhu Valappil [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis] | Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease |
000728 |
Wei-Bin Shen [États-Unis] ; Kimberly A. Mcdowell [États-Unis] ; Aubrey A. Siebert [États-Unis] ; Sarah M. Clark [États-Unis] ; Natalie V. Dugger [États-Unis] ; Kimberly M. Valentino [États-Unis] ; H. A. Jinnah [États-Unis] ; Carole Sztalryd [États-Unis] ; Paul S. Fishman [États-Unis] ; Christopher A. Shaw [Canada] ; M. Samir Jafri [États-Unis] ; Paul J. Yarowsky [États-Unis] | Environmental neurotoxin‐induced progressive model of parkinsonism in rats |
000735 |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis] | Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis |
000738 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
000742 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada] | Dopamine turnover increases in asymptomatic LRRK2 mutations carriers |
000770 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
000788 |
Ronald B. Postuma [Canada] ; Paola A. Lanfranchi [Canada] ; Helene Blais [Canada] ; Jean-Francois Gagnon [Canada] ; Jacques Y. Montplaisir [Canada] | Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder |
000790 |
Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis] | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
000797 |
Behnam A. Baghbaderani [Canada] ; Karim Mukhida [Canada] ; Arindom Sen [Canada] ; Michael S. Kallos [Canada] ; Murray Hong [Canada] ; Ivar Mendez [Canada] ; Leo A. Behie [Canada] | Bioreactor expansion of human neural precursor cells in serum‐free media retains neurogenic potential |
000821 |
Daniel Weintraub [États-Unis] ; Mandy Sohr [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Royaume-Uni] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study |
000825 |
Pei-Fang Guo [Canada] ; Prabir Bhattacharya [États-Unis] ; Nawwaf Kharma [Canada] | Advances in Detecting Parkinson’s Disease |
000826 |
Manon Bouchard [Canada] ; Sylvain Chouinard [Canada] ; And Oksana Suchowersky [Canada] | Adult cases of congenital muscular torticollis successfully treated with botulinum toxin |
000833 |
Kelvin L. Chou [États-Unis] ; Melissa M. Amick [États-Unis] ; Jason Brandt [États-Unis] ; Richard Camicioli [Canada] ; Karen Frei [États-Unis] ; Darren Gitelman [États-Unis] ; Jennifer Goldman [États-Unis] ; John Growdon [États-Unis] ; Howard I. Hurtig [États-Unis] ; Bonnie Levin [États-Unis] ; Irene Litvan [États-Unis] ; Laura Marsh [États-Unis] ; Tanya Simuni [États-Unis] ; Alexander I. Tröster [États-Unis] ; Ergun Y. Uc [États-Unis] | A recommended scale for cognitive screening in clinical trials of Parkinson's disease |
000835 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | A positive influence of vision on motor symptoms during sensory attention focused exercise for Parkinson's disease |
000836 |
Adrian W. Laxton [Canada] ; David F. Tang-Wai [Canada] ; Mary Pat Mcandrews [Canada] ; Dominik Zumsteg [Suisse] ; Richard Wennberg [Canada] ; Ron Keren [Canada] ; John Wherrett [Canada] ; Gary Naglie [Canada] ; Clement Hamani [Canada] ; Gwenn S. Smith [États-Unis] ; Andres M. Lozano [Canada] | A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease |
000844 |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
000872 |
R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; M. Vendette [Canada] ; J. Y. Montplaisir [Canada] | Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease |
000874 |
R. Nandhagopal ; L. Kuramoto ; M. Schulzer ; E. Mak ; J. Cragg ; Chong S. Lee ; J. Mckenzie [États-Unis] ; S. Mccormick ; A. Samii [États-Unis] ; A. Troiano ; T. J. Ruth ; V. Sossi ; R. De La Fuente-Fernandez ; Donald B. Calne ; A. J. Stoessl [Canada] | Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study |
000875 |
Katerina Venderova ; Ghassan Kabbach ; Elizabeth Abdel-Messih ; Yi Zhang ; Robin J. Parks ; Yuzuru Imai ; Stephan Gehrke ; Johnny Ngsee ; Matthew J. Lavoie ; Ruth S. Slack ; Yong Rao ; Zhuohua Zhang [États-Unis] ; Bingwei Lu ; M. Emdadul Haque [Canada] ; David S. Park [Canada] | Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease |
000878 |
T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada] | Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study |
000893 |
Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada] | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease |
000938 |
Bernard Ravina [États-Unis] ; Jordan Elm [États-Unis] ; Richard Camicioli [Canada] ; Peter G. Como [États-Unis] ; Laura Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; Daniel Weintraub [États-Unis] | The course of depressive symptoms in early Parkinson's disease |
000947 |
A. C. Ludolph [Allemagne] ; J. Kassubek [Allemagne] ; B. G. Landwehrmeyer [Allemagne] ; E. Mandelkow [Allemagne] ; E. Mandelkow [Allemagne] ; D. J. Burn [Royaume-Uni] ; D. Caparros-Lefebvre [France] ; K. A. Frey [États-Unis] ; J. G. De Yebenes [Espagne] ; T. Gasser [Allemagne] ; P. Heutink [Pays-Bas] ; G. Höglinger [Allemagne] ; Z. Jamrozik [Pologne] ; K. A. Jellinger [Autriche] ; A. Kazantsev [États-Unis] ; H. Kretzschmar [Allemagne] ; A. E. Lang [Canada] ; I. Litvan [États-Unis] ; J. J. Lucas [Espagne] ; P. L. Mcgeer [Canada] ; S. Melquist [États-Unis] ; W. Oertel [Allemagne] ; M. Otto [Allemagne] ; D. Paviour [Royaume-Uni] ; T. Reum [Allemagne] ; A. Saint-Raymond [Royaume-Uni] ; J. C. Steele ; M. Tolnay [Suisse] ; H. Tumani [Allemagne] ; J. C. Van Swieten [Pays-Bas] ; M. T. Vanier [France] ; J. Vonsattel [États-Unis] ; S. Wagner [Allemagne] ; Z. K. Wszolek [États-Unis] | Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options |
000950 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | Symptom and gait changes after sensory attention focused exercise vs aerobic training in Parkinson's disease |
000955 |
Benedicte Ballanger [Canada] ; Thilo Van Eimeren [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Philippe Boulinguez [France] ; Giovanna Pellecchia [Canada] ; Sylvain Houle [Canada] ; Yu Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Stimulation of the subthalamic nucleus and impulsivity: Release your horses |
000956 |
Seung U. Kim [Canada, Corée du Sud] ; Jean De Vellis [États-Unis] | Stem cell‐based cell therapy in neurological diseases: A review |
000A33 |
Jean-François Gagnon [Canada] ; Mélanie Vendette [Canada] ; Ronald B. Postuma [Canada] ; Catherine Desjardins [Canada] ; Jessica Massicotte-Marquez [Canada] ; Michel Panisset [Canada] ; Jacques Montplaisir [Canada] | Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease |
000A37 |
Bart F. L. Van Nuenen [Pays-Bas, Allemagne] ; Thilo Van Eimeren [Canada] ; Joyce P. M. Van Der Vegt [Pays-Bas, Allemagne] ; Carsten Buhmann [Allemagne] ; Christine Klein [Allemagne] ; Bastiaan R. Bloem [Pays-Bas] ; Hartwig R. Siebner [Allemagne, Danemark] | Mapping preclinical compensation in Parkinson's disease: An imaging genomics approach |
000A45 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; Jing Xie [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France] | Long‐term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease |
000A51 |
Jonathan Kimmelman [Canada, États-Unis] ; Alex John London [États-Unis] ; Bernard Ravina [États-Unis] ; Tim Ramsay [Canada] ; Mark Bernstein [Canada] ; Alan Fine [Canada] ; Frank W. Stahnisch [Canada] ; Marina Elena Emborg [États-Unis] | Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations |
000A62 |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |
000A65 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
000A68 |
Richard M. Camicioli ; Thomas P. Bouchard ; Martin J. Somerville [Canada] | Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients |
000A70 |
Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada] | Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond |
000A73 |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
000A81 |
Stephanie A. Cobb [États-Unis] ; Christian Wider [États-Unis] ; Owen A. Ross [États-Unis] ; Ignacio F. Mata [États-Unis] ; Charles H. Adler [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Ruey-Meei Wu [Taïwan] ; Robert Hauser [États-Unis] ; Keith A. Josephs [États-Unis] ; Jonathan Carr [Afrique du Sud] ; Katrina Gwinn [États-Unis] ; Michael G. Heckman [États-Unis] ; Jan O. Aasly [Norvège] ; Timothy Lynch [Irlande (pays)] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Gregory Kapatos [États-Unis] ; Matthew J. Farrer [États-Unis] | GCH1 in early‐onset Parkinson's disease |
000A88 |
Christian Wider [États-Unis] ; Justus C. Dachsel [États-Unis] ; Alexandra I. Soto [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Mei Yue [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan O. Aasly [Norvège] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; John Q. Trojanowski [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Deborah Mash [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Dennis W. Dickson [États-Unis] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis] | FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression |
000B03 |
Behzad Elahi [Canada] ; Behrad Elahi [Iran] ; Robert Chen [Canada] | Effect of transcranial magnetic stimulation on Parkinson motor function—Systematic review of controlled clinical trials |
000B07 |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease |
000B09 |
C. Warren Olanow [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; Anthony E. Lang [Canada] ; Jose A. Obeso [Espagne] | Dopaminergic transplantation for parkinson's disease: Current status and future prospects |
000B62 |
M. M. Lewis [États-Unis] ; A. B. Smith [États-Unis] ; M. Styner [États-Unis] ; H. Gu [États-Unis] ; R. Poole [États-Unis] ; H. Zhu [États-Unis] ; Y. Li [États-Unis] ; X. Barbero [États-Unis] ; S. Gouttard [États-Unis] ; M. J. Mckeown [Canada] ; R. B. Mailman [États-Unis] ; X. Huang [États-Unis] | Asymmetrical lateral ventricular enlargement in Parkinson’s disease |
000B67 |
Andrew Eisen [Canada] | Amyotrophic lateral sclerosis—Evolutionary and other perspectives |
000B78 |
Bernard Ravina [États-Unis] ; Caroline Tanner [États-Unis] ; Diane Dieuliis [États-Unis] ; Shirley Eberly [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Stanley Fahn [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stephen Grate [États-Unis] ; Roger Kurlan [États-Unis] ; Anthony E. Lang [Canada] ; Kenneth Marek [États-Unis] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Robin Elliott [États-Unis] ; Ira Shoulson [États-Unis] | A longitudinal program for biomarker development in Parkinson's disease: A feasibility study |
000B80 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts |
000B95 |
I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada] | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients |
000C11 |
Ian R. A. Mackenzie [Canada] ; Dean Foti [Canada] ; John Woulfe [Canada] ; Trevor A. Hurwitz [Canada] | Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions |
000C14 |
Maria Fraraccio [Canada] ; Alain Ptito [Canada] ; Abbas Sadikot [Canada] ; Michel Panisset [Canada] ; Alain Dagher [Canada] | Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease |
000C17 |
K. Mukhida [Canada] ; M. Hong [Canada] ; G. B. Miles [Canada] ; T. Phillips [Canada] ; B. A. Baghbaderani [Canada] ; M. Mcleod [Canada] ; N. Kobayashi [Canada] ; A. Sen [Canada] ; L. A. Behie [Canada] ; R. M. Brownstone [Canada] ; I. Mendez [Canada] | A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats |
000C56 |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins |
000C68 |
Manho Kim ; Soon-Tae Lee ; Kon Chu ; Seung U. Kim [Canada] | Stem cell‐based cell therapy for Huntington disease: A review |
000C79 |
Genevieve Bureau [Canada] ; Fanny Longpré [Canada] ; M. Martinoli [Canada] | Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation |
000C84 |
R B Postuma [Canada] ; J F Gagnon [Canada] ; M. Vendette [Canada] ; K. Charland [Canada] ; J. Montplaisir [Canada] | REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features |
000D01 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada] | Predictors of deterioration in health‐related quality of life in Parkinson's disease: Results from the DATATOP trial |
000D33 |
Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada] | Neuropathy as a potential complication of levodopa use in Parkinson's disease |
000D37 |
Thomas Gilljam [Canada] ; Edgar Jaeggi [Canada] ; Robert M. Gow [Canada] | Neonatal supraventricular tachycardia: outcomes over a 27‐year period at a single institution |
000D40 |
Gregor K. Wenning ; Nadia Stefanova ; Kurt A. Jellinger [Autriche] ; Werner Poewe [Autriche] ; Michael G. Schlossmacher [Canada, États-Unis] | Multiple system atrophy: A primary oligodendrogliopathy |
000D56 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Katia Charland [Canada] ; Jacques Montplaisir [Canada] | Manifestations of Parkinson disease differ in association with REM sleep behavior disorder |
000D72 |
Shen-Yang Lim [Canada] ; Andrew H. Evans [Australie] ; Janis M. Miyasaki [Canada] | Impulse Control and Related Disorders in Parkinson's Disease |
000D77 |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
000D79 |
Marc D. Pell [Canada] ; Laura Monetta [Canada] | How Parkinson's Disease Affects Non‐verbal Communication and Language Processing |
000D87 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
000E18 |
Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie] | Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? |
000E19 |
W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] | Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease |
000E24 |
Werner Poewe [Autriche] ; S. Gauthier [Canada] ; D. Aarsland [Norvège] ; J. B. Leverenz [États-Unis] ; P. Barone [Italie] ; D. Weintraub [États-Unis] ; E. Tolosa [Espagne] ; B. Dubois [France] | Diagnosis and management of Parkinson’s disease dementia |
000E30 |
Darcy Litteljohn [Canada] ; Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Cyclooxygenase‐2 deficiency modifies the neurochemical effects, motor impairment and co‐morbid anxiety provoked by paraquat administration in mice |
000E34 |
Alison R. Oates [Canada] ; Jim S. Frank [Canada] ; Aftab E. Patla [Canada] ; Karen Vanooteghem [Canada] ; Fay B. Horak [États-Unis] | Control of dynamic stability during gait termination on a slippery surface in Parkinson's disease |
000E73 |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) |
000E78 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
000E81 |
J R Powell ; C J Swanton [Canada] | A critique of studies evaluating glyphosate effects on diseases associated with Fusarium spp. |
000E91 |
Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
000F43 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
000F71 |
Ana Djarmati [Allemagne] ; Miodrag Gužvi [Allemagne, Serbie] ; Anne Grünewald [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; David K. Simon [États-Unis] ; Angela M. Kaindl [Allemagne] ; Peter Vieregge [Allemagne] ; Anders O. H. Nygren [Pays-Bas] ; Christian Beetz [Allemagne] ; Katja Hedrich [Allemagne] ; Christine Klein [Allemagne] | Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation‐dependent probe amplification |
001000 |
P. T. T. Ly [Canada] ; S. Singh [Canada] ; C. A. Shaw [Canada] | Novel environmental toxins: Steryl glycosides as a potential etiological factor for age‐related neurodegenerative diseases |
001011 |
Wei Zhang [États-Unis, République populaire de Chine] ; Shannon Dallas [États-Unis] ; Dan Zhang [États-Unis] ; Jian-Ping Guo [Canada] ; Hao Pang [États-Unis] ; Belinda Wilson [États-Unis] ; David S. Miller [États-Unis] ; Biao Chen [République populaire de Chine] ; Wanqin Zhang [République populaire de Chine] ; Patrick L. Mcgeer [Canada] ; Jau-Shyong Hong [États-Unis] ; Jing Zhang [États-Unis] | Microglial PHOX and Mac‐1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha‐synuclein |
001013 |
Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial |
001016 |
Richard M. Camicioli [Canada] ; Christopher C. Hanstock [Canada] ; Thomas P. Bouchard [Canada] ; Myrlene Gee [Canada] ; Nancy J. Fisher [Canada] ; W. R. Wayne Martin [Canada] | Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease |
001025 |
Vera Michel [Canada] ; Marica Bakovic [Canada] | Lipid rafts in health and disease |
001030 |
Panida Piboolnurak [Canada, Thaïlande] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Janis M. Miyasaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Yu-Yan W. Poon [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] ; Elena Moro [Canada] | Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease |
001063 |
Eric V. Regehr [États-Unis] ; Nicholas J. Lunn [Canada] ; Steven C. Amstrup [États-Unis] ; Ian Stirling [Canada] | Effects of Earlier Sea Ice Breakup on Survival and Population Size of Polar Bears in Western Hudson Bay |
001068 |
Quincy J. Almeida [Canada] ; James S. Frank [Canada] ; Eric A. Roy [Canada] ; Aftab E. Patla [Canada] ; Mandar S. Jog [Canada] | Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease |
001069 |
Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study |
001075 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
001098 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
001109 |
Zubin Master [Canada] ; Marcus Mcleod [Canada] ; Ivar Mendez | Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease |
001116 |
Connie Marras [Canada] ; Alexander Kopp [Canada] ; Feng Qiu [Canada] ; Anthony E. Lang [Canada] ; Kathy Sykora [Canada] ; Kenneth I. Shulman [Canada] ; Paula A. Rochon [Canada] | Antipsychotic use in older adults with Parkinson's disease |
001137 |
Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashburn [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas] | A meta‐analysis of six prospective studies of falling in Parkinson's disease |
001152 |
Patrick S. R. Davidson [Canada] ; David Anaki [Canada] ; Jean A. Saint-Cyr [Canada] ; Tiffany W. Chow [Canada] ; Morris Moscovitch [Canada] | Exploring the recognition memory deficit in Parkinson's disease: estimates of recollection versus familiarity |
001174 |
David A. Grimes [Canada] ; Fabin Han [Canada] ; Michel Panisset [Canada] ; Lemuel Racacho [Canada] ; Fengxia Xiao [Canada] ; Ruobing Zou [Canada] ; Kelly Westaff [Canada] ; Dennis E. Bulman [Canada] | Translated mutation in the Nurr1 gene as a cause for Parkinson's disease |
001191 |
Shubhayan Sanatani [Canada] ; Gregory Wilson ; Charles R. Smith ; Robert M. Hamilton ; William G. Williams [Canada] ; Ian Adatia [États-Unis] | Sudden Unexpected Death in Children with Heart Disease |
001194 |
Galit Kleiner-Fisman [États-Unis] ; Jan Herzog [Allemagne] ; David N. Fisman [États-Unis] ; Filippo Tamma [Italie] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Anthony E. Lang [Canada] ; Günther Deuschl [Allemagne] | Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes |
001214 |
Anthony E. Lang [Canada] ; Steven Gill [Royaume-Uni] ; Nik K. Patel [Royaume-Uni] ; Andres Lozano [Canada] ; John G. Nutt [États-Unis] ; Richard Penn [États-Unis] ; David J. Brooks [Royaume-Uni] ; Gary Hotton [Royaume-Uni] ; Elena Moro [Canada] ; Peter Heywood [Canada] ; Matthew A. Brodsky [États-Unis] ; Kim Burchiel [États-Unis] ; Patrick Kelly [États-Unis] ; Arif Dalvi [États-Unis] ; Burton Scott [États-Unis] ; Mark Stacy [États-Unis] ; Dennis Turner [États-Unis] ; V. G. Frederich Wooten [États-Unis] ; William J. Elias [États-Unis] ; Edward R. Laws [États-Unis] ; Vijay Dhawan [États-Unis] ; A. Jon Stoessl [Canada] ; James Matcham [Royaume-Uni] ; Robert J. Coffey [États-Unis] ; Michael Traub [États-Unis] | Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease |
001223 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
001236 |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
001250 |
Anthony H. V. Schapira [Royaume-Uni] ; Erwan Bezard [France] ; Jonathan Brotchie [Canada] ; Frdric Calon [Canada] ; Graham L. Collingridge [Royaume-Uni] ; Borris Ferger [Allemagne] ; Bastian Hengerer [Allemagne] ; Etienne Hirsch [France] ; Peter Jenner [Royaume-Uni] ; Nicolas Le Novre [Royaume-Uni] ; Jos A. Obeso [Espagne] ; Michael A. Schwarzschild [États-Unis] ; Umberto Spampinato [France] ; Giora Davidai [États-Unis] | Novel pharmacological targets for the treatment of Parkinson's disease |
001263 |
H. Bazzazi [Canada] ; R. B. Clark [Canada] ; W. R. Giles [États-Unis] | Mathematical Simulations of the Effects of Altered AMP‐Kinase Activity on INa and the Action Potential in Rat Ventricle |
001278 |
Wendy R. Galpern [Canada] ; Anthony E. Lang [Canada, États-Unis] | Interface between tauopathies and synucleinopathies: A tale of two proteins |
001299 |
Peter E. Light [Canada] | Familial Wolff‐Parkinson‐White Syndrome: A Disease of Glycogen Storage or Ion Channel Dysfunction? |
001300 |
Eduardo Back Sternick [Brésil] ; Antonio Oliva [États-Unis] ; Luiz P. Magalhães [Brésil] ; Luiz M. Gerken [Brésil] ; Kui Hong [États-Unis] ; Oto Santana [Brésil] ; Pedro Brugada [Belgique] ; Josep Brugada [Espagne] ; Ramon Brugada [Canada] | Familial Pseudo‐Wolff‐Parkinson‐White Syndrome |
001301 |
Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada] | Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation |
001322 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
001327 |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
001328 |
Günther Deuschl [Allemagne] ; Jan Herzog [Allemagne] ; Galit Kleiner-Fisman [États-Unis] ; Cynthia Kubu [États-Unis] ; Andres M. Lozano [Canada] ; Kelly E. Lyons [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Filippo Tamma [Italie] ; Alexander I. Tröster [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Jens Volkmann [Allemagne] ; Valerie Voon [États-Unis] | Deep brain stimulation: Postoperative issues |
001329 |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
001331 |
Oury Monchi [Canada] ; Michael Petrides [Canada] ; Beatriz Mejia-Constain [Canada] ; Antonio P. Strafella [Canada] | Cortical activity in Parkinson's disease during executive processing depends on striatal involvement |
001346 |
Seung U. Kim [Corée du Sud, Canada] ; In H. Park [Corée du Sud] ; Tae H. Kim [Corée du Sud] ; Kwang S. Kim [Corée du Sud] ; Hyun B. Choi [Canada] ; Seok H. Hong [Corée du Sud] ; Jung H. Bang [Corée du Sud] ; Myung A. Lee [Corée du Sud] ; In S. Joo [Corée du Sud] ; Chong S. Lee [Canada] ; Yong S. Kim [Corée du Sud] | Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease |
001365 |
Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon Stoessl | Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications |
001403 |
Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann [Canada] ; Lori K. Smith [Canada] ; Karim Fouad [Canada] | The unilateral 6‐OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis |
001425 |
Melisa Proulx [Canada] ; François P. De Courval [Canada] ; Michael A. Wiseman [Canada] ; Michel Panisset [Canada] | Salivary production in Parkinson's disease |
001481 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment |
001512 |
K. Michno [Canada] ; D. Van De Hoef [Canada] ; H. Wu ; Gl Boulianne [Canada] | Demented flies? using Drosophila to model human neurodegenerative diseases |
001533 |
Richard Camicioli [Canada] ; Ali Rajput [Canada] ; Michelle Rajput [Canada] ; Christian Reece [Canada] ; Haydeh Payami [États-Unis] ; Chunhai Hao [Canada] ; Alex Rajput [Canada] | Apolipoprotein E ϵ4 and catechol‐O‐methyltransferase alleles in autopsy‐proven Parkinson's disease: Relationship to dementia and hallucinations |
001539 |
Guowei Huang [Canada, République populaire de Chine] ; Magdalena Dragan [Canada] ; David Freeman [Canada] ; John X. Wilson [Canada, États-Unis] | Activation of catechol‐O‐methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons |
001560 |
Anthony E. Lang [Canada] ; José A. Obeso [Espagne] | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
001584 |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada] | Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations |
001588 |
M G Carpenter [Suisse, Canada] ; J H J. Allum [Suisse] ; F. Honegger [Suisse] ; A L Adkin [Suisse, Canada] ; B R Bloem [Pays-Bas] | Postural abnormalities to multidirectional stance perturbations in Parkinson’s disease |
001612 |
Rau L De La Fuente-Ferna Ndez [Canada] ; Vesna Sossi [Canada] ; Zhigao Huang [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
001613 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
001619 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Inflammation and the Degenerative Diseases of Aging |
001624 |
Seung U. Kim [Canada] | Human neural stem cells genetically modified for brain repair in neurological disorders |
001652 |
Katja Hedrich [Allemagne] ; Cordula Eskelson [Allemagne] ; Beth Wilmot [États-Unis] ; Karen Marder [États-Unis] ; Juliette Harris [États-Unis] ; Jennifer Garrels [Allemagne] ; Helen Meija-Santana [États-Unis] ; Peter Vieregge [Allemagne] ; Helfried Jacobs [Allemagne] ; Susan B. Bressman [États-Unis] ; Anthony E. Lang [Canada] ; Martin Kann [Allemagne] ; Giovanni Abbruzzese [Italie] ; Paolo Martinelli [Italie] ; Eberhard Schwinger [Allemagne] ; Laurie J. Ozelius [États-Unis] ; Peter P. Pramstaller [Italie, États-Unis] ; Christine Klein [Allemagne] ; Patricia Kramer [États-Unis] | Distribution, type, and origin of Parkin mutations: Review and case studies |
001698 |
Sudeep S. Gill [Canada] ; Paula A. Rochon [Canada] ; Mark Guttman [Canada] ; Andreas Laupacis | The Value of Positron Emission Tomography in the Clinical Evaluation of Dementia |
001707 |
Gil Bub [Canada] ; Katsumi Tateno [Canada] ; Alvin Shrier [Canada] ; Leon Glass [Canada] | Spontaneous Initiation and Termination of Complex Rhythms in Cardiac Cell Culture |
001708 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
001728 |
Richard Camicioli [États-Unis, Canada] ; M. Milar Moore [États-Unis] ; Anthony Kinney [États-Unis] ; Elizabeth Corbridge [États-Unis] ; Kathryn Glassberg [États-Unis] ; Jeffrey A. Kaye [États-Unis] | Parkinson's disease is associated with hippocampal atrophy |
001766 |
Judit Várkonyi [Hongrie] ; Hanna Rosenbaum [Israël] ; Nicole Baumann [France] ; Jennifer J. Mackenzie [Canada] ; Zsuzsa Simon [Hongrie] ; Judith Aharon-Peretz [Israël] ; Jamie M. Walker [États-Unis] ; Nahid Tayebi [États-Unis] ; Ellen Sidransky [États-Unis] | Gaucher disease associated with parkinsonism: Four further case reports |
001768 |
Allan L. Adkin [Canada] ; James S. Frank [Canada] ; Mandar S. Jog [Canada] | Fear of falling and postural control in Parkinson's disease |
001792 |
Taresa Stefurak [Canada] ; David Mikulis [Canada] ; Helen Mayberg [Canada] ; Anthony E. Lang [Canada] ; Stephanie Hevenor [Canada] ; Peter Pahapill [États-Unis] ; Jean Saint-Cyr [Canada] ; Andres Lozano [Canada] | Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: A functional MRI case study |
001808 |
Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada] | Age and severity of nigrostriatal damage at onset of Parkinson's disease |
001834 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
001847 |
Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada] | Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases |
001880 |
David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci |
001915 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
001919 |
Yong B. Lee [Canada, Corée du Sud] ; Atsushi Nagai [Canada, Japon] ; Seung U. Kim [Canada, Corée du Sud] | Cytokines, chemokines, and cytokine receptors in human microglia |
001923 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
001926 |
Azi H. Rajput [Canada] ; Mark E. Fenton [Canada] ; Sam Birdi [Canada] ; Rob Macaulay [Canada] ; David George [Canada] ; Bohdar Rozdilsky [Canada] ; Lee C. Ang [Canada] ; Ambikaipakan Senthilselvan [Canada] ; Oleh Hornykiewicz [Autriche] | Clinical–Pathological study of levodopa complications |
001935 |
David Axelson [Norvège, Canada] ; Inger Johanne Bakken [Norvège] ; Ingrid Susann Gribbestad [Norvège] ; Benny Ehrnholm [Norvège] ; Gunnar Nilsen [Norvège] ; Jan Aasly [Norvège] | Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients |
001939 |
M. Angela Cenci [Suède] ; Ian Q. Whishaw [Canada] ; Timothy Schallert [États-Unis] | Animal models of neurological deficits: how relevant is the rat? |
001953 |
Douglas Coyle [Canada] ; George Wells [Canada] ; Ian Graham [Canada] ; Karen M. Lee [États-Unis] ; Joan E. Peterson [Canada] ; Emmanuel Papadimitropoulos [Canada] | The Impact of Risk on Preference Values: Implications for Evaluations of Postmenopausal Osteoporosis Therapy |
001969 |
Lori L. Jennings [Canada] ; Chunhai Hao [Canada] ; Miguel A. Cabrita [Canada] ; Mark F. Vickers [Canada] ; Stephen A. Baldwin [Royaume-Uni] ; James D. Young [Canada] ; Carol E. Cass [Canada] | Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system |
001A32 |
P. K Pal [Canada] ; Z. K Wszolek [États-Unis] ; A. Kishore [Canada] ; R. De La Fuente-Fernandez [Canada] ; V. Sossi [Canada] ; R. J Uitti [États-Unis] ; T. Dobko [Canada] ; A. J Stoessl [Canada] | Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene) |
001A67 |
Masafumi Fukuda [États-Unis] ; Marc Mentis [États-Unis] ; Maria Felice Ghilardi [États-Unis] ; Vijay Dhawan [États-Unis] ; Angelo Antonini [États-Unis] ; John Hammerstad [États-Unis] ; Andres M. Lozano [Canada] ; Anthony Lang [Canada] ; Kelly Lyons [États-Unis] ; William Koller [États-Unis] ; Claude Ghez [États-Unis] ; David Eidelberg [États-Unis] | Functional correlates of pallidal stimulation for Parkinson's disease |
001B06 |
Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover |
001B10 |
P. K. Pal [Canada] ; C. S. Lee [Canada] ; A. Samii [Canada] ; M. Schulzer [Canada] ; A. J. Stoessl [Canada] ; E. K. Mak [Canada] ; J. Wudel [Canada] ; T. Dobko [Canada] ; J. K. C. Tsui [Canada] | Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki |
001B22 |
I. Mendez [Canada] ; K. A Baker ; M. Hong | Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease |
001B69 |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
001B70 |
K. Adam Baker [Canada] ; Damaso Sadi [Canada] ; Murray Hong [Canada] ; Ivar Mendez [Canada] | Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft |
001B72 |
Dov Frankel [Canada] ; Khalil Mehindate [Canada] ; Hyman M. Schipper [Canada] | Role of heme oxygenase‐1 in the regulation of manganese superoxide dismutase gene expression in oxidatively‐challenged astroglia |
001B94 |
E. Kwan [Canada] ; G. B. Baker [Canada] ; A. Shuaib [Canada] ; L. Ling [Canada] ; K. G. Todd [Canada] | N‐methyl,N‐propargyl‐2‐phenylethylamine (MPPE), an analog of deprenyl, increases neuronal cell survival in thiamin deficiency encephalopathy |
001B95 |
Raúl De La Fuente-Fernández [Canada] ; Asha Kishore [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Nigrostriatal dopamine system and motor lateralization |
001B97 |
Jean A. Saint-Cyr [Canada] ; Lisa L. Trépanier [Canada] | Neuropsychologic assessment of patients for movement disorder surgery |
001C24 |
H. M Schipper [Canada] | Heme oxygenase-1: role in brain aging and neurodegeneration |
001C29 |
R. Horowski [Allemagne] ; L. Horowski [Allemagne] ; S. M. Calne [Canada] ; D. B. Calne [Canada] | From Wilhelm von Humboldt to Hitler—are prominent people more prone to have Parkinson's disease? |
001C40 |
J. M. Van Kampen [Canada] ; E. G. Mcgeer [Canada] ; A. Jon Stoessl [Canada] | Dopamine transporter function assessed by antisense knockdown in the rat: Protection from dopamine neurotoxicity |
001C45 |
Lucie Godbout [Canada] ; Julien Doyon [Canada] | Defective Representation of Knowledge in Parkinson's Disease: Evidence from a Script-Production Task |
001C83 |
Sharon Sharir [Canada] ; Michael A. S. Jewett [Canada] ; Jeremy F. G. Sturgeon [Canada] ; Malcolm Moore [Canada] ; Padraig R. Warde [Canada] ; Charles N. Catton [Canada] ; Mary K. Gospodarowicz [Canada] | PROGRESSION DETECTION OF STAGE I NONSEMINOMATOUS TESTIS CANCER ON SURVEILLANCE: IMPLICATIONS FOR THE FOLLOWUP PROTOCOL |
001D19 |
Mark Loeb [Canada] ; Simor [Canada] ; Lionel Mandell [Canada] ; Paul Krueger [Canada] ; Margaret Mcarthur [Canada] ; Marilyn James [Canada] ; Stephen Walter [Canada] ; Elizabeth Richardson [Canada] ; Michael Lingley [Canada] ; Janet Stout [États-Unis] ; David Stronach [Canada] ; Allison Mcgeer [Canada] | Two Nursing Home Outbreaks of Respiratory Infection with Legionella sainthelensi |
001D45 |
A. Samii [Canada] ; I. M. Turnbull [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; S. Yardley [Canada] ; D. B. Calne [Canada] | Reassessment of unilateral pallidotomy in Parkinson's disease |
001D47 |
Anne Beuter [Canada] ; Anne De Geoffroy [Canada] ; Roderick Edwards [Canada] | Quantitative Analysis of Rapid Pointing Movements in Cree Subjects Exposed to Mercury and in Subjects with Neurological Deficits |
001D53 |
Pierre Chagnon [Canada] ; Mark Gee [Canada] ; Mario Filion [Canada] ; Yves Robitaille [Canada] ; Majid Belouchi [Canada] ; Denis Gauvreau [Canada] | Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French‐Canadian founder population |
001D57 |
Christopher B. Overgaard [Canada] ; David A. Harrison [Canada] ; Samuel C. Siu [Canada] ; William G. Williams [Canada] ; Gary D. Webb [Canada] ; Louise Harris [Canada] | Outcome of previous tricuspid valve operation and arrhythmias in adult patients with congenital heart disease |
001D58 |
Claudia Schwab [Canada] ; Michael Schulzer [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada] | On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam |
001D88 |
Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anthony E. Lang [Canada] ; Esther Cubo [États-Unis] | Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off‐state |
001E31 |
A. H. Rajput [Canada] ; S. Birdi [Canada] | Epidemiology of Parkinson's disease |
001E36 |
D. Hao [Canada] ; J. Seidel [Canada] ; R. Brant [Canada] ; F. Alexander [Canada] ; D. S. Ernst [Canada] ; N. Summers [Canada] ; J. A. Russell [Canada] ; D. A. Stewart [Canada] | COMPLIANCE OF CLINICAL STAGE I NONSEMINOMATOUS GERM CELL TUMOR PATIENTS WITH SURVEILLANCE |
001E88 |
Muenter [États-Unis] ; Lysia S. Forno [États-Unis] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada] ; Demetrius M. Maraganore [États-Unis] ; Richard J. Caselli [États-Unis] ; Haruo Okazaki [États-Unis] ; Frank M. Howard Jr. [États-Unis] ; Barry J. Snow [Nouvelle-Zélande] ; Donald B. Calne [Canada] | Hereditary form of parkinsonism—dementia |
001F24 |
Perl [États-Unis] ; C. Olanow Warren [États-Unis] ; Donald Calne [Canada] | Alzheimer's disease and parkinson's disease: Distinct entities or extremes of a spectrum of neurodegeneration? |
001F33 |
A. H. Rajput [Canada] ; Ryan J. Uitti [États-Unis] ; Alex H. Rajput [États-Unis] ; Kenneth P. Offord [États-Unis] | Timely levodopa (LD) administration prolongs survival in Parkinson's disease |
001F42 |
P. Warde [Canada] ; M. K. Gospodarowicz [Canada] ; D. Banerjee [Canada] ; T. Panzarella [Canada] ; L. Sugar [Canada] ; C. N. Catton [Canada] ; J. F. G. Sturgeon [Canada] ; M. Moore [Canada] ; M. A. S. Jewett [Canada] | Prognostic Factors for Relapse in Stage I Testicular Seminoma Treated With Surveillance |
001F43 |
Ryan J. Uitti [Canada] ; Francois J. G. Vingerhoets [Canada] ; Margo Hayward [Canada] ; Sandra Cooper [Canada] ; Barry J. Snow [Canada] | Positron emission tomography (PET) measurements of striatal D2 receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months' treatment with SINEMET® or SINEMET® CR |
001F56 |
C. Apostolides [Canada] ; E. Sanford [Canada] ; M. Hong [Canada] ; I. Mendez [Canada] | Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells |
001F57 |
Z. K. Wszolek [États-Unis] ; P. Vieregge [Allemagne] ; R. J. Uitti [Canada] ; T. Gasser [Canada] ; O. Yasuhara [Canada] ; P. Mcgeer [Canada] ; K. Berry [États-Unis] ; D. B. Calne [Allemagne] ; F. J. G. Vingerhoets [Allemagne] ; C. Klein [Allemagne] ; R. F. Pfeiffer [États-Unis] | German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia — Longitudinal observations |
001F64 |
M. Goulet [Canada] ; M. Morissette [Canada] ; F. Calon [Canada] ; P. J Blanchet [Canada] ; P. Falardeau [Canada] ; P. J Bédard [Canada] ; T. Di Paolo [Canada] | Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis |
001F65 |
Robert A. Hauser [États-Unis] ; Theresa A. Zesiewicz [États-Unis] ; Stewart A. Factor [États-Unis] ; Mark Guttman [Canada] ; William J. Weiner [États-Unis] | Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness |
001F75 |
Francois J. G. Vingerhoets [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; Snow [Canada] | Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? |
001F96 |
Ivar Mendez [Canada] ; Murray Hong [Canada] | Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase |
001F97 |
Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada] | R(−)-Deprenyl Potentiates Dopamine-Induced Cytotoxicity toward Catecholaminergic Neuroblastoma SH-SY5Y Cells |
002021 |
Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Karen Busenbark [États-Unis] ; Jean Hubble [États-Unis] ; Steve Wilkinson [États-Unis] ; Anthony Lang [Canada] ; Paul Tuite [Canada] ; Elspeth Sime [Canada] ; Andres Lazano [Canada] ; Robert Hauser [États-Unis] ; Teresita Malapira [États-Unis] ; Donald Smith [États-Unis] ; Daniel Tarsy [États-Unis] ; Edison Miyawaki [États-Unis] ; Thorkild Norregaard [États-Unis] ; Theresa Kormos [États-Unis] ; C. Warren Olanow [États-Unis] | High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor |
002044 |
Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; Alex Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada] | Concordance of common movement disorders among familial cases |
002047 |
Jean-Paul Soucy [Canada] ; Abdelghani Mrini [Canada] ; Francine Lafaille [Canada] ; Guy Doucet [Canada] ; Laurent Descarries [Canada] | Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain |
002053 |
Magdy Basta [Canada] ; MBBch [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada] ; Andrew Krahn [Canada] ; John Lee [Canada] | CURRENT ROLE OF PHARMACOLOGIC THERAPY FOR PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA |
002068 |
S. Calne [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; C. Guyette [Canada] ; G. Rohs [Canada] ; S. Hatchard [Canada] ; D. Murphy [Canada] ; J. Hodder [Canada] ; C. Gagnon [Canada] ; S. Weatherby [Canada] ; L. Beaudet [Canada] ; J. Duff [Canada] ; S. Pegler [Canada] | Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS) |
002118 |
Julien Doyon [Canada] ; Carole Bourgeois [Canada] ; Paul Bédard [Canada] | Déficits visuo‐spatiaux associés à la Maladie de Parkinson |
002137 |
Sultan Darvesh [Canada] ; Morris Freedman | Subcortical Dementia: A Neurobehavioral Approach |
002206 |
Frank Q. Ye [Canada] ; Peter S. Allen [Canada] ; Martin [Canada] | Basal ganglia iron content in Parkinson's disease measured with magnetic resonance |
002207 |
J. J. Claus [Pays-Bas] ; E. Mohr [Canada] | Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases |
002234 |
Jean-François Emard [Canada] ; Jean-Pierre Thouez [Canada] ; Denis Gauvreau [Canada] | Neurodegenerative diseases and risk factors: A literature review |
002256 |
Karen M. Semchuk [Canada] ; Edgar J. Love [Canada] | Effects of Agricultural Work and Other Proxy-derived Case-Control Data on Parkinson's Disease Risk Estimates |
002282 |
Claudia Schwab [Canada] ; C. Steele ; Haruhiko Akiyama [Japon] ; G. Mcgeer [Canada] ; L. Mcgeer [Canada] | Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia |
002318 |
Pj Blanchet [Canada] ; B. Gomez-Mancilla [Canada] ; T. Di Paolo [Canada] ; Pj Bédard [Canada] | Is striatal dopaminergic receptor imbalance responsible for levodopa‐induced dyskinesia? |
002325 |
C. Mertens [Canada] ; Diponkar Banerjee [Canada] ; Nahla Al-Mutter [Canada] ; Larry Stitt [Canada] ; C. Bramwell [Canada] ; K. Lala [Canada] | High-dose continuous venous infusion of interleukin-2: Influence of dose and infusion rate on tumoricidal function and lymphocyte subsets |
002377 |
Peter H. Yu [Canada] | Pharmacological and clinical implications of MAO-B inhibitors |
002390 |
C. S. Lee [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; B. J. Snow [Canada] ; J. K. Tsui [Canada] ; S. Clane [Canada] ; J. Hammerstad [Canada] ; D. B. Clane [Canada] | Clinical observations on the rate of progression of idiopathic parkinsonism |
002413 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud [États-Unis] ; J. W. Langston [États-Unis] ; M. Schulzer [Canada] ; Calne [Canada] | Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions |
002419 |
K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. Hornykiewicz | Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects |
002427 |
F. J. G. Vingerhoets [Canada] ; Snow [Canada] ; C. S. Lee [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] | Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism |
002437 |
Gasser [États-Unis, Allemagne] ; Z. K. Wszolek [États-Unis] ; J. Trofatter [États-Unis] ; L. Ozelius [États-Unis] ; R. J. Uitti [Canada] ; C. S. Lee [Canada] ; J. Gusella [États-Unis] ; R. F. Pfeiffer [États-Unis] ; D. B. Calne [Canada] ; X. O. Breakefield [États-Unis] | Genetic linkage studies in autosomal dominant parkinsonism: Evaluation of seven candidate genes |
002451 |
Jonne Wojcieszek [Canada] ; Lang [Canada] ; Joseph Jankovic [États-Unis] ; Paul Greene [États-Unis] ; John Deck [Canada] | Case 1, 1994: Rapidly progressive aphasia, apraxia, dementia, myoclonus, and parkinsonism |
002462 |
Olanow [États-Unis] ; S. Fahn [États-Unis] ; M. Muenter [États-Unis] ; H. Klawans [États-Unis] ; H. Hurtig [États-Unis] ; M. Stern [États-Unis] ; I. Shoulson [États-Unis] ; R. Kurlan [États-Unis] ; J. D. Grimes [Canada] ; Joseph Jankovic [États-Unis] ; M. Hoehn [États-Unis] ; C. H. Markham [États-Unis] ; R. Duvisin [États-Unis] ; O. Reinmuth [États-Unis] ; H. A. Leonard [États-Unis] ; E. Ahlskog [États-Unis] ; R. Feldman [États-Unis] ; L. Hershey [États-Unis] ; M. D. Yahr [États-Unis] | A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease |
002465 |
R. Lemery [Canada] ; M. Talajic [Canada] ; D. Roy [Canada] ; L. Lavoie [Canada] ; B. Coutu [Canada] ; J T Hii [Canada] ; D. Radzik [Canada] ; E. Lavallee [Canada] ; R. Cartier [Canada] | Results of a comparative study of low energy direct current with radiofrequency ablation in patients with the Wolff-Parkinson-White syndrome. |
002535 |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada] | Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata |
002538 |
Fiona E. Parkinson [Canada] ; Alan R. P. Paterson [Canada] ; Jim D. Young [Canada] ; Carol E. Cass [Canada] | Inhibitory effects of propentofylline on [3H]adenosine influx |
002578 |
Richard R. Schneider [Canada] ; D. Bruce Hunter [Canada] ; David Waltner-Toews [Canada] | Nursing disease in mink: ranch-level epidemiology |
002591 |
Gerald Eschun [Canada] ; Dwight Parkinson [Canada] ; Jerry Vriend [Canada] | Changes in hippocampal monoamine concentration following halothane anesthesia and concussion |
002608 |
D. A. Wardle [Canada] ; D. Parkinson [Canada] | The influence of the herbicide glyphosate on interspecific interactions between four soil fungal species |
002609 |
Guylaine Le Dorze [Canada] ; Louise Dionne [Canada] ; John Ryalls [Canada] ; Marie Julien [Canada] ; Lisa Ouellet [Canada] | The effects of speech and language therapy for a case of dysarthria associated with Parkinson's disease |
002616 |
Wszolek [États-Unis, Canada] ; R. F. Pfeiffer [États-Unis] ; M. H. Bhatt [Canada] ; R. L. Schelper [États-Unis] ; M. Cordes [Canada] ; B. J. Snow [Canada] ; R. L. Rodnitzky [États-Unis] ; E. Ch Wolters [Pays-Bas] ; F. Arwert [Pays-Bas] ; D. B. Calne [Canada] | Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration |
002643 |
Scott G. Adams [Canada] ; Anthony E. Lang [Canada] | Can the Lombard effect be used to improve low voice intensity in Parkinson's disease? |
002651 |
J. Flint [Canada] ; E. Black [Canada] ; Irene Campbell-Taylor [Canada] ; F. Gailey [Canada] ; Carey Levinton [Canada] | Acoustic analysis in the differentiation of Parkinson's disease and major depression |
002722 |
D. A. Wardle [Canada, Nouvelle-Zélande] ; D. Parkinson [Canada] | Analysis of co-occurrence in a fungal community |
002759 |
Clyde Hertzman [Canada] ; Michele Wiens ; David Bowering ; Barry Snow ; Donald Calne | Parkinson's disease: A case‐control study of occupational and environmental risk factors |
002868 |
Carl Pinsky [Canada] ; Ranjan Bose [Canada] | Pyridine and other coal tar constituents as free radical-generating environmental neurotoxicants |
002882 |
L. Mcgeer [Canada] ; S. Itagaki [Canada] ; G. Mcgeer [Canada] | Expression of the histocompatibility glycoprotein HLA-DR in neurological disease |
002900 |
Anne E. Taylor [Canada] ; J. A. Saint-Cyr [Canada] ; A. E. Lang [Canada] | PARKINSON'S DISEASE |
002949 |
Ann E. Taylor [Canada] ; Jean A. Saint-Cyr [Canada] ; Anthony E. Lang [Canada] ; Frank T. Kenny [Canada] | PARKINSON'S DISEASE AND DEPRESSION |
002951 |
Ann E. Taylor [Canada] ; J. A. Saint-Cyr [Canada] ; A. E. Lang [Canada] | FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE |
002973 |
Kish [Canada] ; Ali Rajput [Canada] ; Joseph Gilbert [Canada] ; Bohdan Rozdilsky [Canada] ; Li-Jan Chang [Canada] ; Kathleen Shannak [Canada] ; Oleh Hornykiewicz [Canada, Autriche] | Elevated γ‐aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: Correlation with striatal dopamine loss |
002975 |
Mark Guttman [Canada] ; Seeman [Canada] ; Gavin P. Reynolds ; Peter Riederer [Autriche] ; Kurt Jellinger [Autriche] ; Wallace W. Tourtellotte [États-Unis] | Dopamine D2 receptor density remains constant in treated Parkinson's disease |
002A34 |
André Barbeau [Canada] | Diagnostic problems in Parkinson's disease |
002A54 |
Rajput [Canada] ; Kenneth P. Offord [États-Unis] ; C. Mary Beard [États-Unis] ; Leonard T. Kurland [États-Unis] | Epidemiology of parkinsonism: Incidence, classification, and mortality |
002A65 |
Owen B. White [Canada] ; Jean A. Saint-Cyr [Canada] ; R. David Tomlinson [Canada] ; James A. Sharpe [Canada] | OCULAR MOTOR DEFICITS IN PARKINSON'S DISEASE |
002A66 |
Owen B. White [Canada] ; Jean A. Saint-Cyr [Canada] ; James A. Sharpe [Canada] | OCULAR MOTOR DEFICITS IN PARKINSON'S DISEASE |
002B15 |
A. E. Lang [Royaume-Uni, Canada] ; N. Quinn [Royaume-Uni] ; S. Brincat [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Parkes [Royaume-Uni] | Pergolide in late‐stage Parkinson disease |
002B22 |
Jerilynn C. Prior [Canada] ; E. C. Cameron [Canada] ; W. J. Knickerbocker [Canada] ; Vincent P. Sweeney [Canada] ; O. Suchowersky [Canada] | Dialysis encephalopathy and osteomalacic bone disease |
002B27 |
A. E. Lang [Royaume-Uni, Canada] ; Marsden [Royaume-Uni] ; J. A. Obeso [Royaume-Uni] ; J. D. Parkes [Royaume-Uni] | Alcohol and Parkinson disease |
002B60 |
Alan J. Parkinson [États-Unis] ; H. G. Muchmore [États-Unis] ; T. A. Mcconnell [Canada] ; L. V. Scott [États-Unis] ; J. A. R. Miles [Fidji] | SEROLOGIC EVIDENCE FOR PARAINFLUENZAVIRUS INFECTION DURING ISOLATION AT SOUTH POLE STATION, ANTARCTICA |
002B73 |
R. Crapper [Canada] ; S. Quittkat [Canada] ; S. Krishnan [Canada] ; J. Dalton [Canada] ; U. De Boni [Canada] | Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy |
002B86 |
Allan Purdy [Canada] ; Hahn [Canada] ; Henry J. M. Barnett [Canada] ; Paul Bratty [Canada] ; Dildar Ahmad [Canada] ; Kenneth G. Lloyd [Canada] ; Edith G. Mcgeer [Canada] ; Thomas L. Perry [Canada] | Familial fatal parkinsonism with alveolar hypoventilation and mental depression |
002B87 |
Michel Filion [Canada] | Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey |
002C54 |
P. Widden [Canada] ; D. Parkinson [Canada] | The effects of a forest fire on soil microfungi |
002D46 |
M. C. Palaganas Jr. [Canada] ; J. E. Fay [Canada] ; D. J. Delahaye [Canada] | Paroxysmal ventricular tachycardia in childhood |